337 studies found for:    colorectal | Recruiting | Exclude Unknown | United States
Show Display Options
Rank Status Study
1 Recruiting Ohio Colorectal Cancer Prevention Initiative
Conditions: Lynch Syndrome;   Colorectal Cancer
Interventions: Genetic: LS tumor screening;   Genetic: Genetic testing;   Behavioral: Genetic Counseling;   Other: Biorepository;   Behavioral: Questionnaire
2 Recruiting Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease (IBD);   Primary Sclerosing Cholangitis (PSC);   Colorectal Neoplasms;   Colorectal Cancer
Intervention:
3 Recruiting Adjuvant Aflibercept for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Aflibercept
4 Recruiting RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Condition: Colorectal Cancer
Interventions: Drug: RAD011;   Drug: FOLFOX;   Drug: Bevacizumab
5 Recruiting Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM)
Condition: Colorectal Cancer
Interventions: Procedure: Colonoscopy;   Procedure: FIT
6 Recruiting Decision Aid to Technologically Enhance Shared Decision Making
Condition: Colorectal Cancer
Intervention: Behavioral: Colorectal Web
7 Recruiting NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: NKTR-102;   Drug: irinotecan
8 Recruiting Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer;   Colon Cancer;   Rectal Cancer
Intervention: Drug: IMMU-130
9 Recruiting Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Capecitabine and aflibercept
10 Recruiting A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: PF-05212384;   Drug: irinotecan;   Drug: Cetuximab;   Drug: Irinotecan
11 Recruiting Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Imprime PGG + cetuximab;   Drug: Cetuximab
12 Recruiting A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer
Condition: Advanced Metastatic (Stage IV) Colorectal Cancer
Interventions: Drug: PledOx (2 µmol/kg);   Drug: PledOx (10 µmol/kg);   Drug: Placebo (0,9% NaCl)
13 Recruiting S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
Conditions: Anxiety Disorder;   Breast Cancer;   Cognitive/Functional Effects;   Colorectal Cancer;   Depression;   Fatigue;   Pain;   Psychosocial Effects of Cancer and Its Treatment;   Weight Changes
Interventions: Behavioral: behavioral dietary intervention;   Behavioral: exercise intervention;   Other: counseling intervention;   Procedure: quality-of-life assessment
14 Recruiting Exercise and Metformin in Colorectal and Breast Cancer Survivors
Conditions: Colorectal Cancer;   Breast Cancer
Interventions: Behavioral: Exercise training;   Drug: Exercise training plus metformin;   Drug: Metformin;   Other: Educational information
15 Recruiting Phase 2A Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer
Conditions: Metastatic Pancreatic Cancer;   Metastatic Colorectal Cancer
Intervention: Drug: NPC-1C/NEO-102
16 Recruiting A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss
Conditions: Metastatic Colorectal Cancer;   Cachexia;   Weight Loss
Interventions: Drug: MABp1;   Drug: Megestrol Acetate
17 Recruiting Regorafenib as Adjuvant Therapy for Colorectal Cancer (CRC) With Resected Liver Metastases
Condition: Colorectal Neoplasms
Interventions: Drug: Regorafenib (Stivarga, BAY73-4506);   Drug: Placebo
18 Recruiting Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Condition: Colorectal Cancer
Interventions: Drug: Minocycline;   Drug: Placebo;   Behavioral: Questionnaires;   Behavioral: Sensory Test
19 Recruiting Lay Health Workers and Colorectal Cancer Screening Among Chinese Americans
Condition: Colorectal Neoplasms
Interventions: Behavioral: LHWO about CRC;   Behavioral: Nutrition Education + CRC brochure
20 Recruiting Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Cetuximab;   Drug: Neratinib

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years